Understanding SARS-CoV-2 Behavior in Human Cells

The Ongoing Race for Effective Treatments

The global COVID-19 pandemic continues to spread, with thousands of new infections reported daily. Concurrently, researchers are engaged in a critical race to develop effective treatments. A foundational step in this endeavor is a comprehensive understanding of the disease mechanism.

Insights from Recent Research

A recent study published in the journal Cell investigates the interactions between the virus and host cells, focusing on a process known as phosphorylation. This process modifies specific intracellular proteins by adding phosphorous-containing molecules, known as phosphoryl groups. Understanding how phosphorylation operates in the context of COVID-19 may uncover potential therapeutic targets.

Proteomics: A Key Methodology

The research team utilized proteomics to assess changes in protein quantities and their phosphorylation levels. They conducted laboratory experiments using a cell type particularly vulnerable to SARS-CoV-2 infection, allowing them to evaluate how the virus impacts cellular proteins.

Impact on Host Cell Proteins

Findings indicated that infection primarily altered the phosphorylation levels of host-cell proteins, rather than their overall abundance. Most proteins that increased in abundance during infection were identified as viral proteins, indicating that the virus takes over the cellular machinery to replicate itself. Notably, some host proteins involved in preventing blood coagulation were found to be downregulated through phosphorylation, suggesting a possible mechanism for the blood clotting issues observed in certain COVID-19 patients.

Viral Protein Changes Within Host Cells

The study also explored the modifications occurring within viral proteins inside host cells. Proteomics analysis identified 49 phosphorylation sites across seven viral proteins, though the specific functions of these sites remain largely unknown. There is preliminary evidence that phosphorylation at some sites may affect the coronavirus spike protein’s ability to bind to human cell receptors, which is crucial for initiating infection.

Phosphorylation and Cellular Signaling

In healthy human cells, phosphorylation is vital for cellular signaling. The presence of viral proteins was found to enhance certain native signaling pathways involved in mRNA processing and apoptosis while downregulating pathways that respond to infections. This behavior reflects the virus’s strategy to replicate its RNA and evade the host’s immune response.

Timing of Viral Replication

Viral protein levels increased approximately eight hours post-infection, indicating the timeline from viral entry to replication. The extensive alterations in host cell protein phosphorylation demonstrate how the virus manipulates its host. Specifically, changes in up to 97 host kinases highlight the signaling pathways exploited by the virus.

Testing Existing Drugs

By identifying the pathways and proteins involved in the COVID-19 disease process, the research team was able to evaluate existing drugs targeting these areas. They tested 68 drugs, either already approved for human use or in late-stage clinical trials, with many exhibiting antiviral activity. However, it is important to note that these results are limited to laboratory settings, and further studies are necessary to determine their effectiveness in humans.

Conclusion

This study enhances our understanding of how SARS-CoV-2 operates within human cells, identifying numerous pathways and proteins the virus exploits. Consequently, it generates several potential targets for drug therapies aimed at disrupting viral replication. Nonetheless, additional research is essential to confidently establish effective treatments.

Written by Michael McCarthy
1. Bouhaddou M, Memon D, Meyer B, White KM, Rezelj VV, Marrero MC, et al. The Global Phosphorylation Landscape of SARS-CoV-2 Infection. Cell. 2020.
Image by Pete Linforth from Pixabay